 Alterity Therapeutics NASDAQ: ATHE shares are trading lower on Wednesday.This is a potential sell-off after the stock increased over 200 yesterday following the company announcing it will present at two upcoming conferences and is expected to report positive data for its treatment for Parkinsons Disorder MSA.Alterity Therapeutics is engaged in research collaboration with Takeda for the treatment of Parkinsons disease gastrointestinal neuropathology. The companys lead drug candidate-PBT2 is being developed for the treatment of Alzheimers and Huntingtons diseases. It has also advanced a drug candidate for Parkinsons disease and other movement disorders PBT434 and brain cancer PBT519, which are in preclinical toxicology testing.Alterity Therapeutics shares were trading down 15.47 to 2.90 at time of publication on Wednesday. The stock has a 52-week high of 5.15 and a 52-week low of 28 cents.See more from Benzinga Why Alteritys Stock Is Trading Higher Today Why Alterity Therapeutics Stock Is Trading Higher TodayC 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. 